Breathe BioMedical Inc.
Initial Public Offering - Preliminary - Friday, July 5, 2024
Company Description
Breathe BioMedical Inc.is a medical technology company focused on developing a breath test to be used as an adjunctive test to mammography screening to detect early-stage breast cancer in women with dense breast tissue. Breath analytics involves the collection, processing, and analysis of breath samples to identify biomarker patterns associated with specific diseases.
| Address: |
191 Halifax St. Moncton, New Brunswick, E1C 9R6 Canada |
|---|---|
| Phone Number: | 506-855-2400 |
| Fax Number: | |
| Website: | www.breathebiomedical.com |
| Industry: | Biotechnology |
|---|---|
| Closing Date: | |
| 1st Day of Trading: | |
| Primary Symbol: | |
| Exchange: |
Proceeds
The net proceeds of the offering will be used to fund research and development of the Company's product candidates and development programs, for working capital and other general corporate purposes and for the repayment of $1.6 million in outstanding indebtedness.
| Gross Proceeds: | |
|---|---|
| Underwrting Fees: | |
| Expense Offering: | |
| Net Proceeds: |
| Lead Underwriter: | Leede Financial Inc. |
|---|---|
| Other Underwriter(s): |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.